Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Phase III, Study of Three Short Course Combination Regimens (Ambisome®, Miltefosine, Paromomycin) Compared With AmBisome® Alone for the Treatment of Visceral Leishmaniasis in Bangladesh

The recruitment status of this study is unknown because the information has not been verified recently.
Verified July 2011 by Drugs for Neglected Diseases.
Recruitment status was  Recruiting
Sponsor:
Collaborators:
Shaheed Surhawardy Medical College and Hospital
International Centre for Diarrhoeal Disease Research, Bangladesh
Information provided by:
Drugs for Neglected Diseases
ClinicalTrials.gov Identifier:
NCT01122771
First received: May 11, 2010
Last updated: July 1, 2011
Last verified: July 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: July 2012
  Estimated Primary Completion Date: December 2011 (Final data collection date for primary outcome measure)